It seems ENZC will far surpass CYDY, which, to my knowledge, doesn't have anywhere nears what ENZC offers: combo of Clone3 & ITV-1 Patents~ Holds key to the Cure for COVID/HIV-AIDS with the ONLY monoclonal antibody that is all-human-all-natural. And will likely cure many other serious diseases.
ENZC's Patents can also target/block the site on the virus(es) that is the doorway for allowing replication of itself in the infected human body and/or morphing/mutating into other strains of its own virus, or into other viruses. ENZC's Patented Products would BLOCK all this from happening.
So ENZC has the best cure for COVID-19/HIV-AIDS (whose viruses have same "corollary structure", as being: 1/ the most effective- proven 98% effective against HIV-AIDS by 5 major Universities, including Harvard & Duke, 2/ the safest~ no side-effects (ALL Human/ALL Natural)~ starts with Human B-Cell of previously-infected COVID patient who has recovered~ it DOES NOT begin by immunizing or humanizing mice/rats and then taking tissues/cells from such, along with other chemicals, and injecting this mixture into a human being who has COVID, and 3/ the cheapest to manufacture.
Therefore, I expect ENZC to far outstrip CYDY in its PPS performance.